Emphysema is a chronic obstructive pulmonary disease characterized by irreversible expansion of the alveolar spaces, which leads to loss of elasticity of the lungs and impaired gas exchange. The main cause of emphysema is long-term exposure to harmful factors such as smoking and air pollution, which leads to damage to the alveoli and deterioration of their function. Symptoms of the disease include shortness of breath, wheezing, coughing, and deterioration in the quality of life. The difficulty in diagnosing and treating emphysema is due to the progressive nature of the disease and the variety of its manifestations, which requires an integrated approach to therapeutic measures and supportive care.
History of the disease and interesting historical facts
The study of emphysema dates back to the 19th century, when its pathological changes were first described. Doctors began to associate emphysema with smoking and occupational risks associated with working in polluted environments. One of the first medical studies devoted to emphysema is considered to be the work of the British physician Richard S. Bailey in 1821, who described in detail the symptoms and morphological changes of the lungs. In the 20th century, especially after World War II, interest in emphysema increased, which coincided with the rise in smoking in Western countries. In the 1960s, the first series of large-scale studies were conducted establishing a link between smoking and chronic lung diseases, including emphysema.
Epidemiology
Emphysema is one of the most common forms of chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), COPD was the third leading cause of death worldwide in 2020. It is important to note that the incidence of emphysema and COPD tends to increase in developing countries due to increased smoking and worsening living conditions. For example, among smokers, it is estimated that about 20-30% of the population suffers from emphysema. Overall, the prevalence of emphysema varies across countries and regions, but averages 2-5% among adults.
Genetic predisposition to this disease
Genetic predisposition to emphysema involves various mutations in a number of genes, the most well-known of which is the **SERPINA1** gene encoding alpha-1-antitrypsin. Deficiency of this protein can accelerate the development of emphysema, especially in combination with environmental factors. Another group of genes involved in the pathogenesis are associated with inflammatory processes and oxidative stress. This includes mutations in genes associated with cytokines and antioxidant defense. Emphysema can develop in patients with a family history of the disease, which confirms the importance of genetic factors in this context.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of emphysema:
- Smoking is the main and most significant risk factor.
- Long-term exposure to chemicals and toxins such as dust, smoke, fumes and air pollution, especially in manufacturing facilities.
- Age – The risk of developing emphysema increases with age, especially after age 40.
- Family history of lung disease - Having relatives with emphysema or other forms of COPD increases your risk.
- Chronic respiratory infections, which can contribute to the destruction of lung tissue.
Diagnosis of this disease
Diagnosis of emphysema includes several stages:
- The main symptoms are shortness of breath, chronic cough, wheezing, fatigue and weight loss.
- Lab tests: Complete blood count, blood gas tests, and alpha-1 antitrypsin levels.
- Radiological examinations: Chest X-rays can show characteristic features of emphysema, such as enlarged lung fields and changes in the lung contour. Computed tomography (CT) scans provide more detailed information, allowing the diagnosis of less severe lesions.
- Other diagnostic tests: Lung function tests (spirometry) are used to assess the patency of the airways and the degree of obstruction.
- Differential diagnosis: angiomatosis, bronchial asthma, interstitial lung diseases and other pathologies requiring exclusion.
Treatment
Treatment for emphysema includes various approaches aimed at reducing symptoms and improving the quality of life of patients:
- General treatment: Lifestyle changes, including stopping smoking and improving working and living conditions.
- Pharmacological treatment: bronchodilators, inhaled corticosteroids, mucolytics and antibiotics if there is an infection.
- Surgical treatment: In some cases, surgery such as bulectomy or lung transplant may be recommended, especially in patients who do not respond to conservative treatment.
- Other treatments include physiotherapy, breathing exercises and oxygen therapy to improve respiratory function and reduce shortness of breath.
List of medications used to treat this disease
- Salbutamol (beta-2 agonist)
- Budesonide (inhaled corticosteroid)
- N-acetylcysteine (mucolytic)
- Tosepelin (beta-2 agonist)
- Amocid (antibiotic)
Disease monitoring
Emphysema monitoring includes regular consultations and examinations aimed at assessing the progression of the disease, as well as the effectiveness of the treatment. Control stages:
- Routine visits to your doctor to evaluate your lung function.
- Spirometry and blood gas assessment to monitor respiratory function.
- Assess the patient's general condition and possible complications such as pulmonary hypertension.
The prognosis for people with emphysema depends on the extent of the disease and the presence of comorbidities. Complications may include respiratory failure, lung infections, and cardiovascular disorders.
Age-related features of the disease
Emphysema may present differently depending on the age group. In older patients, the disease is often accompanied by comorbid conditions such as cardiovascular disease and osteoporosis, which significantly worsens the quality of life. In younger people, emphysema is usually associated with smoking and occupational risks, and may develop more aggressively. It is important to take a comprehensive approach to treatment depending on the patient's age, taking into account individual characteristics.
Questions and Answers
- What are the main symptoms of emphysema? The main symptoms include shortness of breath, chronic cough, wheezing and fatigue. These manifestations can worsen the patient's general condition and reduce the quality of life.
- What is the connection between smoking and emphysema? Smoking is the main risk factor for developing emphysema. Long-term exposure to tobacco smoke causes damage to lung tissue and progression of the disease.
- Can emphysema be cured? Emphysema is a chronic disease, so a complete cure is not possible. However, it is possible to control symptoms and improve quality of life with the right treatment.
- What diagnostic tests are used to detect emphysema? Physical examination, spirometry, chest x-rays, CT scans, and laboratory tests are used to diagnose emphysema.
- What preventive measures can be used to reduce the risk of emphysema? The main prevention is stopping smoking, avoiding exposure to toxic substances, regular medical examinations and an active lifestyle.
Dr. Oleg Korzhikov recommends paying attention to the following tips for the prevention and management of emphysema:
- Stop smoking and avoid second-hand smoke.
- Get regular medical checkups to detect lung diseases early.
- Engage in physical activity, choosing exercises that will not make you short of breath.
- Eat a diet rich in antioxidants to support lung function.
- Monitor the air quality in your surroundings and try to minimize your exposure to pollutants.
By following these recommendations, you can significantly improve your quality of life and prevent the progression of emphysema.
